spiraprilat has been researched along with Cardiac Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imai, S; Ishihara, T; Nakazawa, M; Okuhira, M; Takahashi, Y | 1 |
| Bellissant, E; Chau, NP; Gerbeau, C; Giudicelli, JF; Richard, C; Thuillez, C | 1 |
1 trial(s) available for spiraprilat and Cardiac Failure
| Article | Year |
|---|---|
Pharmacokinetic-pharmacodynamic model relating spiraprilat plasma concentrations to systemic and regional hemodynamic effects in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Enalapril; Heart Failure; Hemodynamics; Humans; Middle Aged; Models, Biological; Peptidyl-Dipeptidase A; Pulmonary Circulation; Pulmonary Wedge Pressure; Regional Blood Flow; Vascular Resistance | 1997 |
1 other study(ies) available for spiraprilat and Cardiac Failure
| Article | Year |
|---|---|
Effects of spiraprilat, an angiotensin-converting enzyme inhibitor, on anesthetized dogs in a new model of acute left ventricular failure.
Topics: Adenosine Triphosphate; Anesthesia; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Coronary Vessels; Disease Models, Animal; Dogs; Enalapril; Heart Failure; Lactates; Lactic Acid; Methoxamine; Microspheres; Myocardium; Oxygen Consumption; Phosphocreatine; Vascular Resistance; Ventricular Function, Left | 1993 |